Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: The role of nuclear factor-κB pathway activation

Patrizia Russo, Alessia Catassi, Davide Malacarne, Stefano Margaritora, Alfredo Cesario, Luigi Festi, Antonino Mulé, Luigi Ferri, Pierluigi Granone

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

BACKGROUND. Despite the best and most aggressive, often integrated, standard therapeutic approaches for mesothelioma, overall survival remains very poor. The actual failure points out clearly the need for the development of novel therapy. One of the promising paths of experimentation is artificial induction of apoptosis. A therapeutic strategy that relies on the down-regulation of BCL-XL inhibition nuclear factor κB (NF-κB) with a combination of SN38 and tumor necrosis factor (TNF) was studied in human mesothelioma cell lines (MSTO-221H, IST-MES1, IST-MES2, MPP89, H28, H513, H2052, and H290). METHODS AND RESULTS. Cell proliferation (clonogenic assay) was inhibited strongly by the combination of TNF and SN38. Examining the persistence of the NF-κB complexes using an electrophoretic mobility-shift assay, it appeared that they still were present at 24 hours in TNF-treated cells. In SN38-treated cells, NF-κB complexes persisted for 6 hours. In cells that were treated with combined SN38 and TNF, NF-κB complexes disappeared quickly and became undetectable at 6 hours. In flow cytometry analysis, only cells that were treated with combined SN38 and TNF demonstrated significant cellular accumulation in the sub-G0-G1 phase, suggesting a specific induction of apoptosis. Morphologic examination (4,6-diamidino-2- phenylindole staining and electron microscopy) and internucleosomal DNA fragmentation (gel ladder) confirmed rigorously the induction of apoptosis. CONCLUSIONS. Because of NF-κB inhibition with the combination of SN38 and TNF, the expression of BCL-XL (both the protein [Western blot analysis] and the mRNA [reverse transcriptase-polymerase chain reaction analysis]) was down-regulated, cytochrome c was released into the cytoplasm, caspase 3 was activated (Western blot analysis), and, consequently, apoptosis was triggered. The authors hope that the results of the current study may contribute to the design and implementation of a novel therapeutic approach that improves patients' responses to treatment for mesothelioma.

Original languageEnglish
Pages (from-to)1503-1518
Number of pages16
JournalCancer
Volume103
Issue number7
DOIs
Publication statusPublished - Apr 1 2005

Fingerprint

Mesothelioma
Tumor Necrosis Factor-alpha
Apoptosis
Western Blotting
Therapeutics
Cell Cycle Resting Phase
G1 Phase
Electrophoretic Mobility Shift Assay
DNA Fragmentation
Cytochromes c
Reverse Transcriptase Polymerase Chain Reaction
Caspase 3
Electron Microscopy
Flow Cytometry
Cytoplasm
Down-Regulation
Gels
Cell Proliferation
Staining and Labeling
Cell Line

Keywords

  • Apoptosis
  • BCL-XL
  • Camptothecin
  • Caspase 3
  • Cell cycle
  • DNA damage
  • Malignant pleural mesothelioma
  • Nuclear factor-κB
  • Survival
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells : The role of nuclear factor-κB pathway activation. / Russo, Patrizia; Catassi, Alessia; Malacarne, Davide; Margaritora, Stefano; Cesario, Alfredo; Festi, Luigi; Mulé, Antonino; Ferri, Luigi; Granone, Pierluigi.

In: Cancer, Vol. 103, No. 7, 01.04.2005, p. 1503-1518.

Research output: Contribution to journalArticle

Russo, P, Catassi, A, Malacarne, D, Margaritora, S, Cesario, A, Festi, L, Mulé, A, Ferri, L & Granone, P 2005, 'Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: The role of nuclear factor-κB pathway activation', Cancer, vol. 103, no. 7, pp. 1503-1518. https://doi.org/10.1002/cncr.20924
Russo, Patrizia ; Catassi, Alessia ; Malacarne, Davide ; Margaritora, Stefano ; Cesario, Alfredo ; Festi, Luigi ; Mulé, Antonino ; Ferri, Luigi ; Granone, Pierluigi. / Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells : The role of nuclear factor-κB pathway activation. In: Cancer. 2005 ; Vol. 103, No. 7. pp. 1503-1518.
@article{00662da195ee499fbba8eafd57d084d7,
title = "Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: The role of nuclear factor-κB pathway activation",
abstract = "BACKGROUND. Despite the best and most aggressive, often integrated, standard therapeutic approaches for mesothelioma, overall survival remains very poor. The actual failure points out clearly the need for the development of novel therapy. One of the promising paths of experimentation is artificial induction of apoptosis. A therapeutic strategy that relies on the down-regulation of BCL-XL inhibition nuclear factor κB (NF-κB) with a combination of SN38 and tumor necrosis factor (TNF) was studied in human mesothelioma cell lines (MSTO-221H, IST-MES1, IST-MES2, MPP89, H28, H513, H2052, and H290). METHODS AND RESULTS. Cell proliferation (clonogenic assay) was inhibited strongly by the combination of TNF and SN38. Examining the persistence of the NF-κB complexes using an electrophoretic mobility-shift assay, it appeared that they still were present at 24 hours in TNF-treated cells. In SN38-treated cells, NF-κB complexes persisted for 6 hours. In cells that were treated with combined SN38 and TNF, NF-κB complexes disappeared quickly and became undetectable at 6 hours. In flow cytometry analysis, only cells that were treated with combined SN38 and TNF demonstrated significant cellular accumulation in the sub-G0-G1 phase, suggesting a specific induction of apoptosis. Morphologic examination (4,6-diamidino-2- phenylindole staining and electron microscopy) and internucleosomal DNA fragmentation (gel ladder) confirmed rigorously the induction of apoptosis. CONCLUSIONS. Because of NF-κB inhibition with the combination of SN38 and TNF, the expression of BCL-XL (both the protein [Western blot analysis] and the mRNA [reverse transcriptase-polymerase chain reaction analysis]) was down-regulated, cytochrome c was released into the cytoplasm, caspase 3 was activated (Western blot analysis), and, consequently, apoptosis was triggered. The authors hope that the results of the current study may contribute to the design and implementation of a novel therapeutic approach that improves patients' responses to treatment for mesothelioma.",
keywords = "Apoptosis, BCL-XL, Camptothecin, Caspase 3, Cell cycle, DNA damage, Malignant pleural mesothelioma, Nuclear factor-κB, Survival, Tumor necrosis factor",
author = "Patrizia Russo and Alessia Catassi and Davide Malacarne and Stefano Margaritora and Alfredo Cesario and Luigi Festi and Antonino Mul{\'e} and Luigi Ferri and Pierluigi Granone",
year = "2005",
month = "4",
day = "1",
doi = "10.1002/cncr.20924",
language = "English",
volume = "103",
pages = "1503--1518",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells

T2 - The role of nuclear factor-κB pathway activation

AU - Russo, Patrizia

AU - Catassi, Alessia

AU - Malacarne, Davide

AU - Margaritora, Stefano

AU - Cesario, Alfredo

AU - Festi, Luigi

AU - Mulé, Antonino

AU - Ferri, Luigi

AU - Granone, Pierluigi

PY - 2005/4/1

Y1 - 2005/4/1

N2 - BACKGROUND. Despite the best and most aggressive, often integrated, standard therapeutic approaches for mesothelioma, overall survival remains very poor. The actual failure points out clearly the need for the development of novel therapy. One of the promising paths of experimentation is artificial induction of apoptosis. A therapeutic strategy that relies on the down-regulation of BCL-XL inhibition nuclear factor κB (NF-κB) with a combination of SN38 and tumor necrosis factor (TNF) was studied in human mesothelioma cell lines (MSTO-221H, IST-MES1, IST-MES2, MPP89, H28, H513, H2052, and H290). METHODS AND RESULTS. Cell proliferation (clonogenic assay) was inhibited strongly by the combination of TNF and SN38. Examining the persistence of the NF-κB complexes using an electrophoretic mobility-shift assay, it appeared that they still were present at 24 hours in TNF-treated cells. In SN38-treated cells, NF-κB complexes persisted for 6 hours. In cells that were treated with combined SN38 and TNF, NF-κB complexes disappeared quickly and became undetectable at 6 hours. In flow cytometry analysis, only cells that were treated with combined SN38 and TNF demonstrated significant cellular accumulation in the sub-G0-G1 phase, suggesting a specific induction of apoptosis. Morphologic examination (4,6-diamidino-2- phenylindole staining and electron microscopy) and internucleosomal DNA fragmentation (gel ladder) confirmed rigorously the induction of apoptosis. CONCLUSIONS. Because of NF-κB inhibition with the combination of SN38 and TNF, the expression of BCL-XL (both the protein [Western blot analysis] and the mRNA [reverse transcriptase-polymerase chain reaction analysis]) was down-regulated, cytochrome c was released into the cytoplasm, caspase 3 was activated (Western blot analysis), and, consequently, apoptosis was triggered. The authors hope that the results of the current study may contribute to the design and implementation of a novel therapeutic approach that improves patients' responses to treatment for mesothelioma.

AB - BACKGROUND. Despite the best and most aggressive, often integrated, standard therapeutic approaches for mesothelioma, overall survival remains very poor. The actual failure points out clearly the need for the development of novel therapy. One of the promising paths of experimentation is artificial induction of apoptosis. A therapeutic strategy that relies on the down-regulation of BCL-XL inhibition nuclear factor κB (NF-κB) with a combination of SN38 and tumor necrosis factor (TNF) was studied in human mesothelioma cell lines (MSTO-221H, IST-MES1, IST-MES2, MPP89, H28, H513, H2052, and H290). METHODS AND RESULTS. Cell proliferation (clonogenic assay) was inhibited strongly by the combination of TNF and SN38. Examining the persistence of the NF-κB complexes using an electrophoretic mobility-shift assay, it appeared that they still were present at 24 hours in TNF-treated cells. In SN38-treated cells, NF-κB complexes persisted for 6 hours. In cells that were treated with combined SN38 and TNF, NF-κB complexes disappeared quickly and became undetectable at 6 hours. In flow cytometry analysis, only cells that were treated with combined SN38 and TNF demonstrated significant cellular accumulation in the sub-G0-G1 phase, suggesting a specific induction of apoptosis. Morphologic examination (4,6-diamidino-2- phenylindole staining and electron microscopy) and internucleosomal DNA fragmentation (gel ladder) confirmed rigorously the induction of apoptosis. CONCLUSIONS. Because of NF-κB inhibition with the combination of SN38 and TNF, the expression of BCL-XL (both the protein [Western blot analysis] and the mRNA [reverse transcriptase-polymerase chain reaction analysis]) was down-regulated, cytochrome c was released into the cytoplasm, caspase 3 was activated (Western blot analysis), and, consequently, apoptosis was triggered. The authors hope that the results of the current study may contribute to the design and implementation of a novel therapeutic approach that improves patients' responses to treatment for mesothelioma.

KW - Apoptosis

KW - BCL-XL

KW - Camptothecin

KW - Caspase 3

KW - Cell cycle

KW - DNA damage

KW - Malignant pleural mesothelioma

KW - Nuclear factor-κB

KW - Survival

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=15744384132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744384132&partnerID=8YFLogxK

U2 - 10.1002/cncr.20924

DO - 10.1002/cncr.20924

M3 - Article

C2 - 15700263

AN - SCOPUS:15744384132

VL - 103

SP - 1503

EP - 1518

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -